RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information2nd July 2026
Summary: The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its Best practice guidance on patient information leaflets to include arrangements following the UK's exit from the EU. The guidance outlines the legal framework for patient information leaflets and provides best practice recommendations to help marketing authorisation holders produce clear, accessible and user-friendly information that supports the safe and effective use of medicines. It also reinforces the importance of good information design to help patients make informed decisions about their treatment, while clarifying that the document is intended as guidance rather than a legal interpretation of the regulations.
Link: https://www.gov.uk/government/publications/best-practice-guidance-on-patient-information-leaflets